Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Romiplostim safe and effective in phase I/II study in pediatric ITP patients

Dec. 17, 2009

Array BioPharma and Amgen partner for small-molecule glucokinase activator program

Dec. 16, 2009

Kissei discovers SGLT-1 inhibitors for the treatment of diabetes

Dec. 16, 2009

Beneficial effects of SUN-11031 in COPD patients with cachexia reported

Dec. 16, 2009

Abbott submits sNDA to FDA for new dosage strengths of Simcor

Dec. 16, 2009

Takeda describes ASK1 inhibitors

Dec. 15, 2009

ProMetic Life Sciences meets with FDA on regulatory pathway of PBI-1402

Dec. 15, 2009

Phase III program of TAK-085 in hypertriglyceridemia initiated in Japan

Dec. 15, 2009

FDA approves use of Diamyd vaccine in young children in TrialNet GAD diabetes study

Dec. 15, 2009

Protalix Biotherapeutics submits NDA to FDA for taliglucerase alfa for Gaucher's disease

Dec. 11, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
New assay for drug discovery against chemo-induced peripheral neuropathy
BioWorld Science
A group led by researchers at Boston Children’s Hospital established a scalable and reproducible model of paclitaxel-induced axon degeneration and neurotoxicity...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...